OLR1 and coronary artery disorder: The study of Li et al. reported that the post-procedural serum sLOX-1 levels were significantly associated with the risk of in-stent restenosis (ISR) and with the severity of lumen loss in patients with stable coronary artery disease undergoing primary PCI.